S M A Rizvi
Overview
Explore the profile of S M A Rizvi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
125
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qu C, Li Y, Song Y, Rizvi S, Raja C, Zhang D, et al.
Br J Cancer
. 2004 Dec;
91(12):2086-93.
PMID: 15599383
Control of micrometastatic pancreatic cancer remains a major objective in pancreatic cancer treatment. The overexpression of MUC1 mucin plays an important role in cancer metastasis. The aim of this study...
2.
Li Y, Tian Z, Rizvi S, Bander N, Allen B
Prostate Cancer Prostatic Dis
. 2004 Jun;
5(1):36-46.
PMID: 15195129
Limited options for the treatment of prostate cancer have spurred the search for new therapies. One innovative approach is the use of targeted alpha therapy (TAT) to inhibit cancer growth,...
3.
Allen B, Tian Z, Rizvi S, Li Y, Ranson M
Br J Cancer
. 2003 Mar;
88(6):944-50.
PMID: 12644835
The control of micrometastatic breast cancer remains problematic. To this end, we are developing a new adjuvant therapy based on (213)Bi-PAI2, in which an alpha-emitting nuclide ((213)Bi) is chelated to...
4.
Li Y, Rizvi S, Ranson M, Allen B
Br J Cancer
. 2002 Apr;
86(7):1197-203.
PMID: 11953871
A novel alpha-particle emitting ((213)Bi) plasminogen activator inhibitor type 2 construct, which targets the membrane-bound urokinase plasminogen activator on prostate cancer cells, was prepared and evaluated in vitro and in...